Verona Pharma Expects $400 Mln In Cash & Cash Equivalents As Of Dec 31, 2024

Reuters01-07 19:26
Jan 7 (Reuters) - Verona Pharma PLC ::
*VERONA PHARMA PLC - EXPECTS $400 MILLION IN CASH & CASH EQUIVALENTS AS OF DEC 31, 2024
*VERONA PHARMA PLC - EXPECTS $36 MILLION IN Q4 NET PRODUCT SALES RELATED TO PRODUCT SALES OF OHTUVAYRE

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 07-JAN-202511:18:16 GMT
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment